The Serum Institute of India (SII) is all set to restart its phase two and three clinical trials for the COVID-19 vaccine after getting the nod from the Drugs Controller General of India (DCGI).
from Zee News :India National https://ift.tt/3kn5P8o
No comments:
Post a Comment